Introduction
Nasopharyngeal carcinoma (NPC) is a disease with a remarkable racial differentiation. It occurs relatively rare in the United States with an incidence rate generally less than 1/100,000, but it is autochthonic in Southern China and Southeast Asia with an aged-adjusted incidence rate shown to be 30-50/100,000 (1) . NPC is a malignancy arising from the epithelial cells lining the nasopharynx and it is a leading cause of cancer deaths in the southern China and also is the 8th greatest cause of cancer mortality around China (2) . Previous studies show that the incidence of NPC is associated with the combined effects of environmental carcinogens, such as tobacco smoking, consumption of salted fish, and biologic factors, including Epstein-Barr virus (EBV) infection and genetic susceptibility (1, 3, 4) . However, the molecular mechanism of NPC pathogenesis is not yet well known. An abundance of recent research has shown single-nucleotide polymorphisms (SNP), such as cytochrome P450 2E1 (CYP2E1) (5) , cyclin D1 (6) and a series of cytokines involved in the development of NPC (7, 8) , which indicated that NPC carcinogenesis may be due to genetic differences such as SNP.
For more than a century, Vitamin D has been recognized as playing a key role in the normal development and mineralization of a healthy skeleton. However, recent studies showed that more extensive roles for vitamin D were discovered in tissues through the vitamin D receptor (VDR), which is a member of the steroid hormone receptor superfamily. VDR has been found in most tissues and cells and it could arise in a wide variety of biologic responses to 1 α ,25(OH) 2 D 3 . The functional roles of VDR suggest that vitamin D plays additional roles in cellular differentiation and the control of proliferation in a variety of cell types (9) .The VDR gene (VDR) is located on chromosome 12q12-q14. Two common VDR SNPs were investigated intensively for association with various human traits, including Fok I (in exon 2) and Bsm I (in intron 8), (rs10735810, and rs1544410, respectively) (10, 11) . Recent studies suggested that polymorphisms of the VDR gene have been associated with several forms of cancer, such as breast cancer (12) , prostate cancer (13) , and colorectal cancer (14) .
In our previous studies, we have found that gene polymorphisms of some cytokines may contribute to the development of NPC (7, 8) , such as interleukin-1B, interleukin-8, interleukin-10, and transforming growth factor-b1. Therefore, we hypothesized that VDR gene polymorphisms may also be involved in modulating susceptibility to NPC. Therefore, we conducted a hospital-based case-control study to explicate the potential association between VDR Fok I and Bsm I polymorphisms and the risk of NPC in a Chinese Han population.
Materials and Methods

Study population
171 NPC patients and 176 non-cancer controls were recruited in this study. All the patients and controls were unrelated Chinese people, and were selected from the same population living in China between July 2005 and March 2007 ( Table 1 ). All the patients were recruited from West China hospital, Sichuan University. Pathologically confirmed NPC diagnosis was the only selection criterion for patients. The case group (131 males and 40 females) had a mean age (S.D.) of 46.4 (13.2) years. The control group consisted of 176 healthy volunteers who visited the general health check-up division at West China Hospital, Sichuan University. The mean age (S.D.) of the control group (126 males and 50 females) was 44.4 (13.4) years. Selection criteria for controls were no evidence of any personal or family history of cancer or other serious diseases. There was no significant difference between patients and control subjects in terms of gender and age distribution. Written informed consent was obtained from all subjects, and the study was performed with the approval of the ethics committee of Chinese Human Genome.
Genotyping
Genomic DNA was extracted from circulating blood with an extraction kit (Bioteke Corporation, Beijing, China). The VDR Fok I (ref SNP ID: rs10735810) and VDR Bsm I (ref SNP ID: rs1544410) polymorphisms were detected with polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) analysis, as described previously (15, 16) . Approximately 10% of the samples were sequenced to validate the results. In the absence of the restriction site, Fok I and Bsm I genotypes were defined by capital letters (F and B, respectively), and where the restriction site was present the two genotypes were defined by small letters (f and b, respectively).
Statistical analysis
The SPSS statistical software package (version 11.5) was used for all the statistical analyses. Genotype and allele frequencies of VDR Fok I and Bsm I were compared between NPC cases and controls using the chi square test and Fisher's exact test when appropriate, and odds ratio (OR) and 95% confidence intervals (CI) were calculated to assess the relative risk conferred by a particular allele and genotype. Demographic and clinical data between groups were compared using the chi square test and Student's t test. Hardy-Weinberg equilibrium was tested with a goodness of fit the for chi square test with one degree of freedom to compare the observed genotype frequencies among the subjects with the expected genotype frequencies. Statistical significance was assumed at the p < 0.05 level.
Results and Discussion
The genotype and allele frequencies of VDR Fok I and Bsm I polymorphisms between the controls and the cases are shown in Table 2 . Genotype distributions of the two polymorphisms were found to be in accordance with the Hardy-Weinberg equilibrium expectation. Abbreviation: SCC, squamous cell carcinoma. a Numbers in parentheses denote percentage; others include poorly differentiated adenocarcinoma (n = 2) and moderately differentiated SCC(n = 6).
Sub-Saharan Africans (27.9%) than this study's controls (10.2%).
The present study, to our knowledge, is the first to investigate the potential correlation between the VDR Fok I and VDR Bsm I polymorphisms and NPC. In this pilot study, no significant association was found between VDR Fok I and Bsm I polymorphisms and the risk of development of NPC. The result implies that VDR Fok I and VDR Bsm I polymorphisms may not directly contribute to the susceptibility to NPC in the Chinese Han population.
Most of the biologic activities of 1 α ,25(OH) 2 D 3 are mediated by a high-affinity receptor, VDR, which plays a role as a ligand-activated transcription factor. The main steps involved in the modulation of gene transcription by the VDR include binding of ligand, heterodimerization with retinoid X receptor (RXR), binding of the heterodimer to vitamin D receptor elements (VDREs), and recruitment of other nuclear proteins into the transcriptional pre-initiation complex. Therefore, genetic changes of the VDR gene could induce serious defects of gene activation, influencing calcium metabolism, cell proliferation, and immune function (9) . Previous studies also implied that polymorphisms in the gene of VDR were associated with disease susceptibility, such as cancer, immune dysfunction and chronic disease. VDR Fok I polymorphism is a C-to-T transition within exon 2 of the VDR gene, defined by endonuclease Fok I. The VDR Bsm I genotype is at the 3' end of the VDR gene (intron 8), it has been proved that it does not lead to any change in either the transcribed mRNA or the translated protein. However, the two polymorphisms have been reported to be associated with malignancy (12) (13) (14) , including breast cancer, prostate cancer, primary parathyroid tumors, and colorectal cancer. NPC is a malignancy arising from the epithelial cells lining the nasopharynx and it often occurs in Southern China and Southeast Asia. Our previous studies and other studies have shown that a range of cytokines (7, 8) , including IL-1B, interleukin-8, interleukin-10, and transforming growth factor-b1 gene polymorphisms, may contribute to the development of NPC. Therefore, in combination with the correlation with VDR gene alteration and cancer risk, we postulate that VDR Fok I and Bsm I gene polymorphisms may modulate susceptibility to NPC. No significant association, however, was found between VDR Fok I and Bsm I polymorphisms and the risk of NPC in the current study.
In agreement with our findings, some studies have shown that the VDR Fok I polymorphism was not associated with breast cancer (12) , colorectal adenomas (19) , prostate cancer (21) , and systemic lupus erythematosus (SLE) (17) . In addition, some authors reported no associations were found between VDR Bsm I polymorphism in breast cancer (22) , and prostate cancer (23) . However, the association between VDR Fok I and VDR Bsm I polymorphisms between the cases and controls (for VDR Fok I: adjusted OR 1.03, 95% CI: 0.76-1.41; for VDR Bsm I: adjusted OR 0.80, 95% CI: 0.48-1.33).
As a polymorphism in the VDR start code, the frequencies of VDR Fok I genotype and allele between our control group in the present study and those of previous reports in different countries were also compared. Among the studies with Asian controls, mainly Chinese (17) and Japanese controls (18) , the frequencies of F and f alleles were 47.2-60.5% and 39.5-52.8%. The allele distribution of VDR Fok I in this study had no significant difference from that found in Asians from other studies. Among the studies with Caucasian controls, the frequencies of F and f alleles were 65.6-68.8% and 31.2-34.4% (19) . When compared with this study's controls, however, the Caucasian controls showed significantly higher allele F and lower allele f frequencies (p < 0.05). This result was in agreement with previous studies, which concluded the prevalence of the f allele of VDR Fok I polymorphism was 36% and 46% in controls of European and Asian descent, respectively (20) . Furthermore, we compared the VDR Fok I and Bsm I allele frequency in this study's controls with HapMap (the International HapMap Project) genomes data in the National Institutes of Health Single Nucleotide Polymorphism database (dbSNP) (http://www.ncbi.nlm.nih.gov/projects/ SNP/). It was shown that the distribution of the VDR Fok I allele frequency in this study's controls was in agreement with Chinese and European results. However, the frequency of F allele was higher in Japanese (73.3%) and in Sub-Saharan Africans (83.3%) than this study's controls (53.4%). The distribution of VDR Bsm I allele frequency in this study's controls was in agreement with Asians, but differed from Europeans and Sub-Saharan Africans. The frequency of B allele was significantly higher in Europeans (43.8%) and (27) . These debatable results mentioned above may be due to various reasons, including a limited number of cases, or the analysis of different ethnic groups, or environment factors which the individuals were exposed to, or even gene-gene and gene-environment interactions. Most case-control studies reported no association with VDR Fok1 polymorphism and breast caner risk (12) . However, when the samples were matched up to cohorts (1,234 cases, 1,676 controls), a significantly increased risk of breast cancer was observed (28). Chaimuangraj et al. focused on the Chinese Han population and suggested that variations in the distribution of VDR Bsm I in different ethnic groups might contribute to the racial difference in prostate cancer risk (29) . Also there is a significant increase of prostate cancer risk found for African-Americans with the ff genotype but not for US Caucasians (23) . Moreover, Michelle Guy found that when analyzed independently, Fok I was not associated with breast cancer risk (p > 0.05). However, when it was analyzed combined with VDR Bsm1 and poly (A) polymorphism, Fok I did modulate the increased risk associated with the bb/LL genotype, and one or more F alleles together with the bb/LL genotype enhanced breast cancer risk (12) . Furthermore, taking environmental factors into consideration, Li et al. concluded that the VDR Fok1 polymorphism is not an independent risk factor for MM, but it could modulate melanoma risk when it interacts with skin color (p = 0.029), moles (p = 0.017) and number of first-degree relatives with any cancer (p = 0.013) (30) .
This study also has some limitations. One is that the detailed information on the survival from NPC is unavailable, which restricted our further analysis on the role of VDR Fok I and Bsm I in cancer prognosis. Another is that the association between VDR Fok I and Bsm I gene polymorphisms and NPC should be analyzed in different ethnic populations.
In conclusion, we did not find that VDR Fok I and Bsm I gene polymorphisms were associated with the risk of NPC in a Chinese Han population. Nevertheless, due to complex reasons, further studies will be needed to explore the complicated gene-gene interactions and gene-environmental interactions in the susceptibility to NPC, especially in ethnically disparate populations in cohort study samples.
